达努格利通过AMPK途径改善压力过载诱导的心脏重塑
Pan Wang1,2, Zhen Guo3,4,5, Chun-Yan Kong1,2
1Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, P.R. China.
Journal of cellular and molecular medicine
|March 12, 2025
概括
达努格利是一种GLP-1受体激动剂,在压力过载模型中保护心脏重塑. 它通过通过AMPKα-HSP70途径增强自和减少亡来起作用.
科学领域:
- 心脏病学 心脏病学
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 心脏重塑是心血管疾病的一个主要挑战.
- 压力过载 (PO) 显著导致心脏功能障碍.
- 目前用于心脏重塑的治疗策略有限.
研究的目的:
- 为了研究丹努格利 (PF-06882961) 的心脏保护作用,这是一种新的口服GLP-1受体激动剂.
- 阐明达努格利在压力过载引起的心脏重塑中的作用的潜在分子机制.
- 评估达努格利作为治疗心脏病的治疗剂的潜力.
主要方法:
- 在体内和体外模型的压力过载引起的心脏缩和纤维化.
- 在小鼠中使用达努格利 (每天1毫克/公斤,口服8周)
- 对心脏功能,亡反应,自,AMPK酸化和HSP70表达的评估.
- 使用AMPKα2淘汰赛小鼠来确认作用机制.
主要成果:
- 达努格利治疗显著减轻了大动脉带带的小鼠的心脏功能障碍和病态重塑.
- PF治疗减轻了亡反应和增强了自.
- 这些效应通过促进AMPK酸化和增加HSP70表达来调节.
- 在AMPKα2淘汰赛小鼠中,心脏保护作用被废除,突出显示了该途径的作用.
结论:
- 达努格利显示出显著的心脏保护作用,防止压力过载引起的心脏重塑.
- 该机制涉及AMPKα-HSP70信号通路的激活,增强自和减少亡.
- 达努格利在治疗心血管疾病中的心脏重塑方面具有有前途的治疗潜力.
更多相关视频
07:13A Rat Model of Pressure Overload Induced Moderate Remodeling and Systolic Dysfunction as Opposed to Overt Systolic Heart Failure
Published on: April 30, 2020
6.4K
05:58Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
Published on: April 18, 2025
111
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
360
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
360
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
566
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
566
01:22Heart Failure Drugs: Diuretics
318
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
318
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
440
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
440
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.3K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.3K
01:25cAMP-dependent Protein Kinase Pathways
6.1K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.1K